#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Orthostatic hypotension Inflammatory myofibroblastic tumour Severe myoclonic epilepsy of infancy Chronic inflammatory demyelinating polyradiculoneuropathy Malignant neoplasm of choroid Hyperadrenocorticism Hepatocellular carcinoma Endocrine ophthalmopathy Alexander disease Nephropathy Warm autoimmune haemolytic anaemia Autoimmune haemolytic anaemia General anaesthesia Cutaneous T-cell lymphoma recurrent Richter's syndrome More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic – Basic Information Nephrotic syndrome – Trials in Disease Angiosarcoma Immunodeficiency congenital Metachromatic leukodystrophy – Treatment Hyperoxaluria – Life with Disease Piriformis syndrome – Diagnostics Wiskott-Aldrich syndrome – Life with Disease Pituitary-dependent Cushing’s syndrome – Basic Information Leiomyosarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abc-15A-116 Amniotic Membrane, Human Sufentanil Citrate Cpk850 Etrumadenant Faricimab Garadacimab Liraglutide Linezolid Fluorouracil SODIUM SULFIDE NONAHYDRATE Abacavir Sulfate Taletrectinib Dried Ferrous Sulfate Fenoterol Hydrobromide Amy109 Ovolecithin Cladribine Batoprotafib Pseudoephedrine Hydrochloride More therapies…

    Learn about Your Condition

    Pneumonia bacterial Alveolar bone defect Pelvic venous thrombosis Psychotic disorder Intervertebral disc protrusion Osteoporosis Cardiac valve disease Critical illness Infective uveitis Ureteric cancer Marfan's syndrome Liposarcoma Diabetic foot Prodromal Alzheimer's disease Mental disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • ADMILPARANT
    Austria Belgium Czechia Denmark Finland France +9

  • A study to evaluate the safety of SGN-ALPV in patients with advanced solid tumors

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Testicular germ cell cancer
    • Cervix carcinoma
    • Endometrial cancer
    Investigated Drugs:
    • SGN-ALPV
    Denmark The Netherlands Spain Sweden

  • Phase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Temozolomide
    Denmark France Germany Ireland Italy The Netherlands +2

  • Testing Personalized Drug Combination Treatment to Reduce Deaths in Patients with Severe Acute Infections

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infection
    Investigated Drugs:
    • Acetylcysteine
    • Ferric Derisomaltose
    • Hydrocortisone
    Denmark

  • Study of Drug Combination with Pembrolizumab Guided by Blood Biomarkers for Patients with Metastatic Non-Small Cell Lung Cancer

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Lung cancer metastatic
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    Italy

  • A Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Cachexia
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Ponsegromab
    Belgium Bulgaria France Germany Italy Poland +2
Previous Page
1 … 741 742 743 744 745 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!